Respiratory Inhaler Devices Market - Forecast(2024 - 2030)

Report Code: HCR 32171 Report Format: PDF + Excel

Respiratory Inhaler Device Market Overview

Respiratory Inhaler Device Market size is estimated to reach $46.2 billion by 2026, growing at a CAGR of 6.8% during the forecast period 2021-2026. Respiratory inhaler devices are the devices that are hand-held and portable devices that deliver medication to the respiratory organs. These inhaler devices help in reducing the amount of medication that remains in the throat or on the tongue after breathe. Respiratory inhaler devices are increasingly being adopted across the world owing to their ability to control the intake of medication. 

The rise in the demand for dry powder inhalers and soft mist inhalers for asthma treatment, increasing adoption of metered dose inhalers for the treatment of chronic obstructive pulmonary disease (COPD), rise in the demand for combination therapies for respiratory devices, and growing investment by the key players to develop advanced respiratory inhaler devices are the factors that are set to drive the growth of the Respiratory Inhaler Device Market for the period 2021-2026.

Respiratory Inhaler Device Market Report Coverage

The report: “Respiratory Inhaler Device Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Respiratory Inhaler Device Market.
By Product Type: Metered Dose Inhalers, Dry Powder Inhalers, and Soft Mist Inhalers.
By Application: Asthma and Chronic Obstructive Pulmonary Disease (COPD).
By End User: Hospitals and Clinics, Respiratory Care Centers, and Others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa).

Key Takeaways

  • Geographically, North America Respiratory Inhaler Device Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the rise in the adoption of metered dose inhalers for the treatment of asthma.
  • The rise in awareness about proactive asthma management in children in developed nations is driving the Asthma segment. However, the high cost of respiratory inhaler devices is one of the major factors that is said to reduce the growth of the Respiratory Inhaler Device Market.
  • Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Respiratory Inhaler Device Market report.

Respiratory Inhaler Device Market Size, By Product Type, 2020-2026 (USD Million)

Respiratory Inhaler Device Market
For More Details on This Report - Request for Sample

Respiratory Inhaler Device Market Segment Analysis-By Product Type

The Respiratory Inhaler Device Market based on the Product Type can be further segmented into Metered Dose Inhalers, Dry Powder Inhalers, and Soft Mist Inhalers. The Dry Powder Inhalers segment held the largest share in 2020 owing to the factors such as the rise in the adoption of dry powered inhalers as an alternative to aerosol-based inhalers and the growing demand for dry powered inhalers for the treatment of chronic obstructive pulmonary disease (COPD). 

The growing investments by the key players in research and development activities for developing advanced dry powered inhalers is driving the growth of the Respiratory Inhaler Device Market. The Metered Dose Inhalers segment is estimated to be the fastest growing segment with a CAGR of 7.6% over the period 2021-2026. This growth is owing to the factors such as the growing adoption of metered dose inhalers in asthma conditions and the rise in the product launches by key players.

Respiratory Inhaler Device Market Segment Analysis-By Application

The Respiratory Inhaler Device Market based on the Application can be further segmented into Asthma and Chronic Obstructive Pulmonary Disease (COPD). The Asthma segment held the largest share in 2020 owing to the factors such as the increase in the demand for metered dose inhalers and soft mist inhalers for the treatment of asthma and rise in the investment by the key players to develop advanced inhaler devices for asthma treatment. 

The rise in awareness about proactive asthma management in children in developed nations is driving the growth of the Respiratory Inhaler Device Market. The Chronic Obstructive Pulmonary Disease (COPD) segment is estimated to be the fastest growing segment with a CAGR of 8.2% over the period 2021-2026. This growth is owing to the factors such as the rise in the adoption of advanced inhalers in hospitals for the treatment of chronic obstructive pulmonary disease (COPD) and increase in the prevalence of chronic respiratory diseases across the world.

Respiratory Inhaler Device Market Segment Analysis-By Geography

North America held the largest share with 31% of the overall market in 2020. The growth in this segment is owing to the factors such as the rise in the demand for dry powder inhalers and soft mist inhalers for asthma treatment and the rise in the product launches by key players. The increasing adoption of metered dose inhalers for the treatment of chronic obstructive pulmonary disease is driving the growth of the Respiratory Inhaler Device Market. 

Asia-Pacific segment is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as the rise in the adoption of combination therapies for respiratory devices and growing investment by the key players to develop advanced respiratory inhaler devices.

Respiratory Inhaler Device Market Drivers

Increase in the Adoption of Combination Therapies for Asthma

The rise in the adoption of combination therapies for asthma has propelled the demand for respiratory inhalers, such as dry powder inhalers and soft mist inhalers owing to their effective results for the patients. The inhaler devices are becoming one of the best options to induce the combination drug, which is one of the major factors driving the growth of the Respiratory Inhaler Device Market.

Increasing Demand for Metered Dose Inhalers

Metered Dose Inhalers are increasingly being adopted for the treatment of asthma and chronic obstructive pulmonary disease (COPD) owing to their ability to deliver the right amount of medication fast. Many governments in developed nations are also supporting the production of advanced inhaler devices owing to their massive demand, which is further propelling the growth of the Respiratory Inhaler Device Market.

Respiratory Inhaler Device Market Challenges

High Cost of Respiratory Inhaler Devices

The key players in the market are collaborating with other players to carry out various research and development activities for launching advanced respiratory inhalers for the treatment of Asthma and Chronic Obstructive Pulmonary Disease (COPD). However, the high cost of respiratory inhalers is one of the major factors that is estimated to reduce the growth of the Respiratory Inhaler Device Market.

Respiratory Inhaler Device Market Competitive Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Respiratory Inhaler Device Market. Key companies of this market are GlaxoSmithKline PLC, Merck & Co, OMRON Healthcare, AstraZeneca, Teva Pharmaceutical, Novartis, Koninklijke Philips N.V., Boehringer Ingelheim GmbH, Sandoz International GmbH, and Beximco Pharmaceuticals Ltd among others.

Partnerships/Product Launches:

  • In December 2020, OMRON Healthcare has launched WheezeScan for children with Asthma to accurately detect the presence of wheezing in young children and to remove the uncertainty of potential misdiagnosis.

Relevant Reports:

Report Code: HCR 84738

Report Code: HCR 0691

For more Lifesciences and Healthcare Market reports, please click here
1. Respiratory Inhaler Device Market - Overview
    1.1 Definitions and Scope
2. Respiratory Inhaler Device Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by Application
    2.4 Key trends by Geography
3. Respiratory Inhaler Device Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Respiratory Inhaler Device Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Respiratory Inhaler Device Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Respiratory Inhaler Device Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Respiratory Inhaler Device Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Respiratory Inhaler Device Market – By Product Type(Market Size –$Million/$Billion)
    8.1 Metered Dose Inhalers
    8.2 Dry Powder Inhalers
    8.3 Soft Mist Inhalers
9. Respiratory Inhaler Device Market – By Application(Market Size –$Million/$Billion)
    9.1 Asthma
    9.2 Chronic Obstructive Pulmonary Disease (COPD)
10. Respiratory Inhaler Device Market – By End User(Market Size –$Million/$Billion)
    10.1 Hospitals and Clinics
    10.2 Respiratory Care Centers
    10.3 Others
11. Respiratory Inhaler Device Market - By Geography(Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Respiratory Inhaler Device Market - Entropy
13. Respiratory Inhaler Device Market – Industry/Segment Competition Landscape Premium
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Respiratory Inhaler Device Market – Key Company List by Country Premium Premium
15. Respiratory Inhaler Device Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.